Data from Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study

Clinton Yam, Miral Patel, Holly A. Hill, Ryan Sun and 6 more